{"": [110, 1283, 0, 20135, 20183, 0], "Introduction": [1284, 2905, 0], "Purification and characterization of vaccine-elicited human IgG": [2915, 5141, 0], "Passive transfer of IgG to na\u00efve hamster recipients": [5142, 7488, 0], "SARS-CoV-2 challenge and monitoring of clinical disease": [7489, 9437, 0], "Analyses of immune correlates of protection": [9438, 10747, 0], "Results": [2906, 10747, 1], "Discussion": [10748, 14258, 0], "Clinical study design and human plasma samples": [14268, 15239, 0], "IgG purification": [15240, 15911, 0], "Electrochemiluminescence assay (ECLA)": [15912, 17209, 0], "Pseudovirus neutralization assay": [17210, 18576, 0], "Hamster study design": [18577, 19747, 0], "Ethical statement": [19748, 19970, 0], "Reporting Summary": [19971, 20107, 0], "Methods": [14259, 20107, 1], "Supplementary information": [20108, 20183, 1]}